Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology.

PubWeight™: 1.33‹?› | Rank: Top 10%

🔗 View Article (PMID 19602590)

Published in Cancer Res on July 14, 2009

Authors

Lei Gao1, Angelika Michel, Melanie N Weck, Volker Arndt, Michael Pawlita, Hermann Brenner

Author Affiliations

1: Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.

Articles citing this

Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Lett (2010) 1.31

Race, African ancestry, and Helicobacter pylori infection in a low-income United States population. Cancer Epidemiol Biomarkers Prev (2011) 1.26

Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Cancer Epidemiol Biomarkers Prev (2012) 1.13

Opium: an emerging risk factor for gastric adenocarcinoma. Int J Cancer (2013) 1.06

Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC study. Hepatology (2014) 0.97

Association of tooth loss and oral hygiene with risk of gastric adenocarcinoma. Cancer Prev Res (Phila) (2013) 0.92

Association of helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: A ten-year follow-up of the ESTHER cohort study. Oncotarget (2016) 0.90

Epstein-Barr virus infection and gastric cancer: a systematic review. Medicine (Baltimore) (2015) 0.90

Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer. Sci Rep (2014) 0.85

A novel line immunoassay based on recombinant virulence factors enables highly specific and sensitive serologic diagnosis of Helicobacter pylori infection. Clin Vaccine Immunol (2013) 0.84

Helicobacter pylori antibody patterns in Germany: a cross-sectional population study. Gut Pathog (2014) 0.83

Biomarkers of Helicobacter pylori-associated gastric cancer. Gut Microbes (2013) 0.82

Correlations between the CagA Antigen and Serum Levels of Anti-Helicobacter pylori IgG and IgA in Children. J Korean Med Sci (2016) 0.81

Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort. Int J Cancer (2015) 0.79

Risk of gastric cancer by water source: evidence from the Golestan case-control study. PLoS One (2015) 0.78

Ulcerogenic Helicobacter pylori strains isolated from children: a contribution to get insight into the virulence of the bacteria. PLoS One (2011) 0.78

Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain. Front Microbiol (2017) 0.78

Development of an ELISA for Quantitative Detection of Immunoglobulin G (IgG) and IgA Antibodies to Helicobacter pylori for Use in Korean Patients with H. pylori-Associated Diseases. Gut Liver (2013) 0.77

Serological response to Helicobacter pylori infection among Latin American populations with contrasting risks of gastric cancer. Int J Cancer (2015) 0.77

Combination of OipA, BabA, and SabA as candidate biomarkers for predicting Helicobacter pylori-related gastric cancer. Sci Rep (2016) 0.77

Cyanidin 3-O-glucoside reduces Helicobacter pylori VacA-induced cell death of gastric KATO III cells through inhibition of the SecA pathway. Int J Med Sci (2014) 0.77

Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas. Cancer Res (2015) 0.76

Biomarkers for Helicobacter pylori infection and gastroduodenal diseases. Biomark Med (2014) 0.75

Serum Helicobacter pylori FliD antibody and the risk of gastric cancer. Oncotarget (2016) 0.75

Gastric corpus atrophy in gastric cancer screenings: Benefits and drawbacks. Middle East J Dig Dis (2011) 0.75

Validation of a Novel Immunoline Assay for Patient Stratification according to Virulence of the Infecting Helicobacter pylori Strain and Eradication Status. J Immunol Res (2017) 0.75

Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer. Sci Rep (2016) 0.75

Helicobacter pylori antibody responses in association with eradication outcome and recurrence: a population-based intervention trial with 7.3-year follow-up in China. Chin J Cancer Res (2017) 0.75

Diagnosis of Helicobacter pylori: Changes towards the Future. Diseases (2015) 0.75

Articles by these authors

Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39

Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol (2007) 8.05

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet (2008) 6.97

Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet (2008) 6.75

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst (2003) 6.28

Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst (2009) 6.21

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58

Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet (2011) 5.18

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35

A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer (2007) 4.29

Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem (2005) 4.18

Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81

Epidemiology of stomach cancer. Methods Mol Biol (2009) 3.72

Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20

Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst (2010) 3.18

Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol (2009) 3.14

Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol (2006) 3.13

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07

Suppression of non-specific binding in serological Luminex assays. J Immunol Methods (2005) 2.96

Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem (2004) 2.95

Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol (2013) 2.87

Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57

Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004. J Natl Cancer Inst (2008) 2.56

Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med (2012) 2.42

Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst (2006) 2.40

Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet (2011) 2.35

Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med (2010) 2.27

Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease. Eur Heart J (2008) 2.26

Cost-effectiveness of colorectal cancer screening. Epidemiol Rev (2011) 2.24

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet (2013) 2.24

Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol (2013) 2.18

Socioeconomic deprivation and cancer survival in Germany: an ecological analysis in 200 districts in Germany. Int J Cancer (2013) 2.18

Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J (2005) 2.16

Helicobacter pylori protein-specific antibodies and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2013) 2.01

Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol Biomarkers Prev (2007) 2.00

HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J Virol Methods (2002) 1.97

Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist (2010) 1.94

The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer (2008) 1.93

Older smokers' motivation and attempts to quit smoking: epidemiological insight into the question of lifestyle versus addiction. Dtsch Arztebl Int (2009) 1.92

Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin Microbiol (2008) 1.90

Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet (2013) 1.88

Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis. J Clin Oncol (2004) 1.88

Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med (2009) 1.84

19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res (2012) 1.81

Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler Thromb Vasc Biol (2012) 1.80

Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol (2004) 1.80

Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology (2012) 1.79

Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet (2013) 1.78

Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites. Hum Mol Genet (2013) 1.77

Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up. Clin Chem (2012) 1.76

Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res (2012) 1.76

Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy. Gastroenterology (2009) 1.75

Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin Chem (2006) 1.75

Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS One (2008) 1.75

Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany. Am J Epidemiol (2012) 1.74

Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Arch Intern Med (2006) 1.73

Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy. Gastrointest Endosc (2011) 1.72

The performance of methods for correcting measurement error in case-control studies. Epidemiology (2002) 1.71

Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer (2010) 1.69

A systematic review of leukocyte telomere length and age in adults. Ageing Res Rev (2013) 1.67

Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood (2008) 1.65

Calcium, phosphate and the risk of cardiovascular events and all-cause mortality in a population with stable coronary heart disease. Heart (2012) 1.64

Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr (2013) 1.62

Flexible matching strategies to increase power and efficiency to detect and estimate gene-environment interactions in case-control studies. Am J Epidemiol (2002) 1.60

MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev (2011) 1.60

Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res (2012) 1.58

Impact of national smoke-free legislation on home smoking bans: findings from the International Tobacco Control Policy Evaluation Project Europe Surveys. Tob Control (2012) 1.56

Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56

High-risk HPV types and head and neck cancer. Int J Cancer (2014) 1.56

Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet (2013) 1.56

Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients. Gynecol Oncol (2002) 1.56

Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress. Arterioscler Thromb Vasc Biol (2006) 1.56

Epidemiology of Helicobacter pylori infection. Helicobacter (2004) 1.56

Assisted reproductive techniques and risk of exstrophy-epispadias complex: a German case-control study. J Urol (2012) 1.55

Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int J Epidemiol (2011) 1.55

Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. J Clin Microbiol (2009) 1.55

Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol (2007) 1.53

Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut (2012) 1.52

Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination. Clin Cancer Res (2004) 1.51

Recurrent abdominal pain in children: evidence from a population-based study that social and familial factors play a major role but not Helicobacter pylori infection. J Psychosom Res (2003) 1.51

Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. Eur Heart J (2012) 1.51

Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement. Cancer Res (2012) 1.49

High-throughput detection and multiplex identification of cell contaminations. Nucleic Acids Res (2009) 1.49

Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol (2007) 1.49

Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study. Am J Epidemiol (2013) 1.48